Cytokinetics Inc
NASDAQ:CYTK
Income Statement
Earnings Waterfall
Cytokinetics Inc
Revenue
|
7.5m
USD
|
Operating Expenses
|
-503.7m
USD
|
Operating Income
|
-496.2m
USD
|
Other Expenses
|
-30m
USD
|
Net Income
|
-526.2m
USD
|
Income Statement
Cytokinetics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
31
N/A
|
38
+23%
|
45
+18%
|
50
+11%
|
47
-5%
|
43
-8%
|
42
-3%
|
41
-3%
|
29
-29%
|
33
+14%
|
32
-2%
|
83
+160%
|
106
+28%
|
102
-4%
|
99
-3%
|
47
-53%
|
13
-71%
|
14
+8%
|
18
+22%
|
22
+25%
|
32
+42%
|
35
+10%
|
36
+3%
|
31
-13%
|
27
-13%
|
22
-17%
|
19
-16%
|
54
+191%
|
56
+3%
|
59
+5%
|
58
-1%
|
22
-63%
|
70
+227%
|
65
-8%
|
151
+132%
|
148
-2%
|
95
-36%
|
98
+4%
|
10
-90%
|
8
-21%
|
8
-4%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(65)
|
(68)
|
(68)
|
(66)
|
(62)
|
(58)
|
(59)
|
(61)
|
(66)
|
(73)
|
(73)
|
(81)
|
(88)
|
(95)
|
(106)
|
(116)
|
(127)
|
(131)
|
(132)
|
(126)
|
(120)
|
(122)
|
(126)
|
(128)
|
(126)
|
(127)
|
(129)
|
(136)
|
(150)
|
(163)
|
(184)
|
(223)
|
(257)
|
(289)
|
(331)
|
(367)
|
(419)
|
(469)
|
(492)
|
(504)
|
(504)
|
|
Selling, General & Administrative |
(15)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(19)
|
(20)
|
(22)
|
(25)
|
(27)
|
(28)
|
(29)
|
(30)
|
(33)
|
(37)
|
(38)
|
(37)
|
(35)
|
(31)
|
(32)
|
(34)
|
(37)
|
(40)
|
(43)
|
(47)
|
(49)
|
(53)
|
(56)
|
(63)
|
(77)
|
(97)
|
(114)
|
(136)
|
(158)
|
(178)
|
(195)
|
(192)
|
(183)
|
(174)
|
|
Research & Development |
(49)
|
(52)
|
(52)
|
(49)
|
(44)
|
(41)
|
(42)
|
(42)
|
(46)
|
(51)
|
(48)
|
(54)
|
(60)
|
(66)
|
(76)
|
(83)
|
(90)
|
(93)
|
(95)
|
(91)
|
(89)
|
(90)
|
(92)
|
(91)
|
(86)
|
(84)
|
(82)
|
(86)
|
(97)
|
(107)
|
(121)
|
(146)
|
(160)
|
(174)
|
(195)
|
(209)
|
(241)
|
(274)
|
(300)
|
(320)
|
(330)
|
|
Operating Income |
(34)
N/A
|
(30)
+11%
|
(23)
+22%
|
(17)
+28%
|
(15)
+12%
|
(15)
-1%
|
(17)
-15%
|
(20)
-17%
|
(37)
-87%
|
(40)
-8%
|
(41)
-1%
|
2
N/A
|
19
+840%
|
7
-60%
|
(7)
N/A
|
(69)
-920%
|
(113)
-64%
|
(116)
-3%
|
(114)
+2%
|
(104)
+9%
|
(89)
+15%
|
(87)
+2%
|
(91)
-4%
|
(97)
-7%
|
(99)
-2%
|
(105)
-6%
|
(110)
-5%
|
(81)
+26%
|
(94)
-16%
|
(104)
-11%
|
(127)
-22%
|
(201)
-59%
|
(186)
+7%
|
(224)
-20%
|
(180)
+20%
|
(219)
-22%
|
(324)
-48%
|
(371)
-14%
|
(482)
-30%
|
(496)
-3%
|
(496)
0%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(8)
|
(11)
|
(14)
|
(16)
|
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(21)
|
(23)
|
(27)
|
(30)
|
(33)
|
(33)
|
(31)
|
(29)
|
(28)
|
(29)
|
(31)
|
(34)
|
(38)
|
(40)
|
(38)
|
(35)
|
(31)
|
(30)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(25)
|
(25)
|
(22)
|
(22)
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(34)
N/A
|
(30)
+12%
|
(23)
+22%
|
(17)
+29%
|
(15)
+12%
|
(15)
-1%
|
(17)
-15%
|
(20)
-17%
|
(38)
-89%
|
(41)
-10%
|
(42)
-3%
|
0
N/A
|
17
+27 400%
|
3
-82%
|
(14)
N/A
|
(80)
-455%
|
(128)
-59%
|
(132)
-3%
|
(131)
+1%
|
(120)
+8%
|
(106)
+12%
|
(105)
+1%
|
(110)
-4%
|
(118)
-7%
|
(122)
-4%
|
(132)
-8%
|
(140)
-7%
|
(114)
+19%
|
(127)
-12%
|
(135)
-6%
|
(156)
-15%
|
(229)
-47%
|
(215)
+6%
|
(258)
-20%
|
(216)
+16%
|
(282)
-31%
|
(389)
-38%
|
(431)
-11%
|
(540)
-25%
|
(527)
+2%
|
(526)
+0%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(34)
|
(30)
|
(23)
|
(17)
|
(15)
|
(15)
|
(17)
|
(20)
|
(38)
|
(41)
|
(42)
|
0
|
17
|
3
|
(14)
|
(80)
|
(128)
|
(132)
|
(131)
|
(120)
|
(106)
|
(105)
|
(110)
|
(118)
|
(122)
|
(132)
|
(140)
|
(114)
|
(127)
|
(135)
|
(156)
|
(229)
|
(215)
|
(258)
|
(216)
|
(282)
|
(389)
|
(431)
|
(540)
|
(527)
|
(526)
|
|
Net Income (Common) |
(34)
N/A
|
(30)
+12%
|
(23)
+22%
|
(17)
+29%
|
(15)
+12%
|
(15)
-1%
|
(17)
-15%
|
(20)
-17%
|
(38)
-89%
|
(41)
-10%
|
(42)
-3%
|
0
N/A
|
17
+27 400%
|
3
-82%
|
(14)
N/A
|
(80)
-455%
|
(128)
-59%
|
(132)
-3%
|
(131)
+1%
|
(120)
+8%
|
(106)
+12%
|
(105)
+1%
|
(110)
-4%
|
(118)
-7%
|
(122)
-4%
|
(132)
-8%
|
(140)
-7%
|
(114)
+19%
|
(127)
-12%
|
(135)
-6%
|
(156)
-15%
|
(229)
-47%
|
(215)
+6%
|
(258)
-20%
|
(216)
+16%
|
(282)
-31%
|
(389)
-38%
|
(431)
-11%
|
(540)
-25%
|
(527)
+2%
|
(526)
+0%
|
|
EPS (Diluted) |
-1.13
N/A
|
-0.9
+20%
|
-0.63
+30%
|
-0.44
+30%
|
-0.41
+7%
|
-0.39
+5%
|
-0.43
-10%
|
-0.5
-16%
|
-0.97
-94%
|
-1.05
-8%
|
-1.07
-2%
|
0
N/A
|
0.39
N/A
|
0.08
-79%
|
-0.29
N/A
|
-1.49
-414%
|
-2.59
-74%
|
-2.44
+6%
|
-2.4
+2%
|
-2.2
+8%
|
-1.95
+11%
|
-1.93
+1%
|
-1.9
+2%
|
-2
-5%
|
-2.11
-5%
|
-2.24
-6%
|
-2.36
-5%
|
-1.66
+30%
|
-1.97
-19%
|
-1.89
+4%
|
-2.17
-15%
|
-2.84
-31%
|
-2.8
+1%
|
-3.03
-8%
|
-2.51
+17%
|
-3
-20%
|
-4.33
-44%
|
-4.52
-4%
|
-5.63
-25%
|
-5.48
+3%
|
-5.45
+1%
|